HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Krogh Herlin Selected Research

Sulfapyridine

3/2022Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura Krogh Herlin Research Topics

Disease

1Linear IgA Bullous Dermatosis
03/2022

Drug/Important Bio-Agent (IBA)

1DapsoneFDA Link
03/2022
1SulfapyridineFDA Link
03/2022

Therapy/Procedure

1Therapeutics
03/2022